Recent Headlines

Racial disparities in the the U.S. coronavirus epidemic extend to children, according to two sobering government reports released Friday.

Educators, health officials and scientists are still working to understand what it will take to make schools safe in the midst of the COVID-19 pandemic.

Mask wearing, school closures and others measures to fight COVID-19 may hamper the spread of acute flaccid myelitis, a mysterious paralyzing illness.

If the coronavirus has you reaching for hand sanitizer, don’t use one with methanol. It can be toxic if absorbed through the skin, the FDA warns.

Hundreds of thousands of essential workers have kept their kids in child care during the pandemic and, so far, these centers haven’t been big disease spreaders.

Even if a vaccine is declared safe and effective by year’s end, there won’t be enough for everyone who wants it right away.

After a two-month mission to the International Space Station, NASA astronauts Bob Behnken and Doug Hurley are headed home.

Most Read


The U.S. is spending up to $2.1 billion on a COVID-19 vaccine candidate from GlaxoSmithKline and Sanofi Pasteur.

The first wave of coronavirus vaccines might be like a flu shot, experts say, curbing symptoms in some patients but not protecting them from COVID-19.

California has seen fewer COVID-19 deaths than New York -- but many times more than other countries, including Japan, South Korea, Taiwan and Australia

The Trump Administration pushed through a $21-million contract to study whether the active ingredient in Pepcid is an effective treatment for COVID-19.

The more we stay home, the less the coronavirus spread, according to a new study of 211 U.S. counties that are home to more than half all Americans.

The NIH has launched studies of the disproportionate impact of COVID-19 on Black and Latino Americans, hoping to prepare the country for the next epidemic.

Showrunner Krista Vernoff says “Grey’s Anatomy” had to tackle “the medical story of our lifetimes” on the ABC show’s next season.


Results from the Phase 1 clinical trial of Moderna’s coronavirus vaccine show it’s on the right track, though there were serious side effects at high doses.

More headlines